• LAST PRICE
    1.3450
  • TODAY'S CHANGE (%)
    Trending Up0.1150 (9.3496%)
  • Bid / Lots
    1.3400/ 11
  • Ask / Lots
    1.3500/ 25
  • Open / Previous Close
    1.2600 / 1.2300
  • Day Range
    Low 1.2600
    High 1.4194
  • 52 Week Range
    Low 0.8700
    High 22.2200
  • Volume
    950,623
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.23
TimeVolumeANTX
09:32 ET91631.27
09:33 ET264271.3261
09:35 ET131331.31
09:37 ET101001.305
09:39 ET80001.31
09:42 ET173601.3012
09:44 ET871671.3
09:46 ET400921.34
09:48 ET504221.36
09:50 ET480501.34
09:51 ET33111.3398
09:53 ET76001.34
09:55 ET40001.3437
09:57 ET456451.37
10:00 ET359801.36
10:02 ET144971.36
10:04 ET111521.385
10:06 ET493511.375
10:08 ET5551.37
10:09 ET61481.3744
10:11 ET16301.37
10:13 ET10061.375
10:15 ET12741.375
10:18 ET4331.375
10:20 ET69341.374
10:22 ET5001.3753
10:24 ET907561.4194
10:26 ET72081.41
10:27 ET1172501.3899
10:29 ET31461.3791
10:31 ET25571.375
10:33 ET13001.375
10:36 ET182791.36
10:38 ET49081.365
10:42 ET17561.365
10:44 ET25761.365
10:47 ET26671.365
10:49 ET1001.3603
10:51 ET24431.355
10:54 ET16741.358
10:58 ET9501.3592
11:02 ET14031.355
11:05 ET3001.35
11:07 ET1541.36
11:14 ET10001.355
11:16 ET3001.355
11:18 ET501721.33
11:20 ET76891.3303
11:23 ET42561.3394
11:25 ET14001.33
11:27 ET2001.33
11:30 ET5001.33
11:32 ET47931.325
11:34 ET3851.325
11:36 ET16151.325
11:38 ET12301.325
11:39 ET99981.325
11:43 ET2001.325
11:45 ET2001.325
11:48 ET2581.33
11:50 ET6001.325
11:52 ET1001.33
11:56 ET3001.325
11:59 ET1001.33
12:01 ET100561.3497
12:03 ET39001.3489
12:06 ET129001.35
12:08 ET152001.365
12:10 ET1001.365
12:12 ET5001.36
12:14 ET8941.35
12:15 ET26591.34
12:17 ET39101.345
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesANTX
AN2 Therapeutics Inc
36.8M
-0.7x
---
United StatesRAPT
RAPT Therapeutics Inc
36.6M
-0.4x
---
United StatesCERO
CERo Therapeutics Holdings Inc
36.6M
-0.6x
---
United StatesCVM
CEL-SCI Corp
37.2M
-1.0x
---
United StatesINTS
Intensity Therapeutics Inc
37.2M
-2.4x
---
United StatesOSTX
OS Therapies Inc
37.2M
-5.5x
---
As of 2024-11-22

Company Information

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Its initial candidate is epetraborole, which is a potential once-daily, oral treatment with a novel mechanism of action for patients with non-tuberculous mycobacterial (NTM) lung disease, a rare, chronic, and progressive infectious disease caused by bacteria known as mycobacteria, which leads to irreversible lung damage and can be fatal. Epetraborole is designed to produce broad-spectrum antimycobacterial activity through inhibition of an essential and universal step in bacterial protein synthesis. Epetraborole is an investigational, boron-containing, orally bioavailable, small molecule inhibitor of bacterial leucyl-tRNA synthetase (LeuRS), an enzyme that catalyzes the attachment of leucine to transfer RNA (tRNA), molecules, an essential step in protein synthesis.

Contact Information

Headquarters
1800 El Camino Real, Suite DMENLO PARK, CA, United States 94025-3069
Phone
650-331-9090
Fax
---

Executives

Independent Chairman of the Board
Joseph Zakrzewski
President, Chief Executive Officer, Director
Eric Easom
Co-Founder, Head of Biology
Michael Alley
Chief Financial Officer
Lucy Day
Chief Operating Officer, Chief Legal Officer, Corporate Secretary
Joshua Eizen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$36.8M
Revenue (TTM)
$0.00
Shares Outstanding
29.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.04
Book Value
$4.19
P/E Ratio
-0.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.